Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

SCRAS scientists design new inhibitors of protein phosphatases

Aug. 7, 2003

Antimitotic drugs in early development at Pfizer

Aug. 7, 2003

FDA approves Photofrin PDT for high-grade dysplasia in Barrett's esophagus

Aug. 6, 2003

ARS scientists design GILZ-based peptides for use in cancer, inflammation, etc.

Aug. 6, 2003

New antitumor agents in Kyowa Hakko development pipeline

Aug. 6, 2003

Fulvestrant at least as effective as anastrozole in advanced breast cancer

Aug. 6, 2003

MorphoSys and Schering AG collaboration yields positive animal data

Aug. 6, 2003

Maxim discusses discovery and development of apoptosis inducers at cancer meeting

Aug. 5, 2003

Small-molecule Bcl-2 inhibitor with apoptosis-inducing effects in cancer cells

Aug. 5, 2003

Bexxar launched in U.S.

Aug. 5, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...